Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus

2002153 citationsJournal Articlebronze Open Access

Authors

Abstract

Long-term administration of fluvastatin prevents further worsening of arterial biomechanics in haemodialysis patients with type 2 diabetes mellitus, even in the presence of serum lipid levels in the normal range.

Topics & Keywords

Cardiovascular Health and Disease Prevention Blood Pressure and Hypertension Studies Diabetes, Cardiovascular Risks, and Lipoproteins

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Nephrology Dialysis Transplantation

Volume 17, Issue 8, pp. 1513-1517

DOI: 10.1093/ndt/17.8.1513

Field-Weighted Citation Impact: 8.49